Abstracts tagged "fibromyalgia"

Abstract Number: 2064 • 2014 ACR/ARHP Annual Meeting
Assessment of the Spanish Version of the American College Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia
B Casanueva¹, F Garcia-Fructuoso², R Belenguer³, C Alegre⁴, R López-Mejías⁵, F Genre⁵, J.V. Moreno⁶, J.L. Hernandez⁷ and MA González-Gay⁵, ¹Rheumatologist. Rheumatology Service at the Specialist Clinic of Cantabria, Santander, Spain, ²Rheumatologist. CIMA Hospital, Barcelona, Spain, ³Rheumatologist. 12 de Octubre Hospital., Valencia, Spain, ⁴Rheumatology, Hospital Universitari Vall d'Hebron, Barcelona, Spain, ⁵Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IDIVAL, Santander, Spain, ⁶Rheumatologist. Vall D’Hebron Hospital, Barcelona, Spain, ⁷Internist. Marqués de Valdecilla Hospital. IDIVAL., Santander, Spain
Background/Purpose: Fibromyalgia (FM) requires an expert clinical examination that impedes an easy assessment of diagnostic criteria of American College Rheumatology (ACR) 1990 in some health…
Abstract Number: 1100 • 2014 ACR/ARHP Annual Meeting
System Review: The Most Common Symptoms of Fibromyalgia Patients Other Than Pain, Fatigue, Insomnia, and Cognitive Dysfunction
Robert S. Katz¹ and Jessica L. Polyak², ¹Rush Medical College, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: Fibromyalgia patients are somatically sensitive. The frequently complain of symptoms other than the core ones used for the diagnosis- pain, fatigue, poor sleep and…
Abstract Number: 2063 • 2014 ACR/ARHP Annual Meeting
Analysis of the Fibromyalgia Rapid Screening Tool Spanish Version to Detect Fibromyalgia in Primary Health Care Centers
B Casanueva¹, R Belenguer², Jv Moreno³, J Urtiaga⁴, B Urtiaga⁵, F Genre⁶, R López-Mejías⁶, Jl Hernandez⁷ and MA González-Gay⁶, ¹Rheumatologist. Rheumatology Service at the Specialist Clinic of Cantabria, Santander, Spain, ²Rheumatologist. 12 de Octubre Hospital., Valencia, Spain, ³Rheumatologist. Vall D’Hebron Hospital, Barcelona, Spain, ⁴Professor of French., Madrid, Spain, ⁵Professor of Spanish language and Literature, Madrid, Spain, ⁶Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IDIVAL, Santander, Spain, ⁷Internist. Marqués de Valdecilla Hospital. IDIVAL, Santander, Spain
Background/Purpose: The Fibromyalgia Rapid Screening Tool (FiRST) is a brief, simple and straightforward self-administered questionnaire with excellent discriminative value, of potential value for the detection…
Abstract Number: 1096 • 2014 ACR/ARHP Annual Meeting
Fibromyalgia Patients Who Have More Symptoms at Their Initial Office Visit Tend to Have a Worse Clinical Course
Robert S. Katz¹, Ben J. Small², Alexandra Small³ and Hannah Bond⁴, ¹Rush Medical College, Chicago, IL, ²MacNeal Hospital, Berwyn, IL, ³University of Illinois College of Medicine, Chicago, IL, ⁴Rheumatology Associates, Chicago, IL
Background/Purpose: Patients with the fibromyalgia syndrome (FMS) experience pain, insomnia, fatigue, and memory/concentration problems. But some fibromyalgia patients also have many additional somatic symptoms. We…
Abstract Number: 2061 • 2014 ACR/ARHP Annual Meeting
Unexpectedly High Prevalence of Immunoglobulin Deficiency in Fibromyalgia
Xavier Caro and Earl Winter, Fibromyalgia Research and Treatment Center, Northridge, CA
Background/Purpose: It has recently been shown that Fibromyalgia (FM) is commonly associated with clinical evidence of neuropathic pain language, laboratory evidence of small fiber…
Abstract Number: 1095 • 2014 ACR/ARHP Annual Meeting
Treatment of Fibromyalgia with Neurostimulation: A Randomized, Double-Blinded, Sham-Controlled Trial
R Michael Gendreau^1,2, Donald Deering³, Judith Gendreau¹ and Jeffrey Hargrove⁴, ¹Gendreau Consulting, LLC, Poway, CA, ²Cerephex Corporation, Los Altos, CA, ³St. Joseph Mercy Oakland, Pontiac, MI, ⁴Research & Development, Cerephex Corporation, Los Altos, CA
Background/Purpose: NeuroPoint is a medical device designed to provide noninvasive brain stimulation using a proprietary approach to deliver very low energy levels to deep brain…
Abstract Number: 2059 • 2014 ACR/ARHP Annual Meeting
Muscle Tension Is Increased in Fibromyalgia
Robert S. Katz¹ and Kerri Swiatnicki², ¹Rush Medical College, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: Fibromyalgia patients have and widespread pain and tender muscles. Muscle tenderness was part of the older ACR criteria for the diagnosis of fibromyalgia. We…
Abstract Number: 1094 • 2014 ACR/ARHP Annual Meeting
Work Productivity and Healthcare Utilization in Patients with Fibromyalgia and Comorbid Depression Taking Antidepressant Medication
Jaren Landen¹, Claire Burbridge², Elizabeth Masters³, Pritha Bhadra Brown⁴, Joseph Scavone¹, Birol Emir⁴, Richard Vissing⁵, Andrew Clair⁴ and Lynne Pauer⁶, ¹Pfizer Inc, Groton, CT, ²Pfizer Ltd, Walton Oaks, United Kingdom, ³Health Economics and Outcomes Research, Pfizer Inc, New York, NY, ⁴Pfizer Inc, New York, NY, ⁵Pfizer Inc, Louisville, KY, ⁶445 Eastern Point Road, Pfizer Inc, Groton, CT
Background/Purpose Patients with fibromyalgia (FM) experience pain, sleep disruption, fatigue, and other symptoms that limit activity, impacting work productivity and increasing healthcare utilization. Here, we…
Abstract Number: 133 • 2013 ACR/ARHP Annual Meeting
Cross-Sectional Neurocognitive Data Do Not Support a Transition From Fibrofog To Alzheimer’s Disease In Fibromyalgia Patients
Robert S. Katz¹ and Frank Leavitt², ¹Rush Medical College, Chicago, IL, ²Rush University Medical Center, Chicago, IL
Background/Purpose: The issue of progressive decline in cognitive abilities is a source of concern to many patients with fibromyalgia. The fear of progressing from fibrofog…
Abstract Number: 1084 • 2013 ACR/ARHP Annual Meeting
Age Distribution of Women With Idiopathic and Traumatic Fibromyalgia
Robert S. Katz¹ and Frank Leavitt², ¹Rush Medical College, Chicago, IL, ²Rush University Medical Center, Chicago, IL
Background/Purpose: Fibromyalgia has both idiopathic and post traumatic forms. The idiopathic type is insidious in onset, becoming established without a known triggering event. The post-traumatic…
Abstract Number: 134 • 2013 ACR/ARHP Annual Meeting
Lower Socioeconomic Status Associates With Increased Symptom Severity and Functional Impairment In Fibromyalgia
Mary-Ann Fitzcharles¹, Emmanouil Rampakakis^2,3, Peter A. Ste-Marie⁴, John S. Sampalis^2,3 and Yoram Shir⁴, ¹Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ²JSS Medical Research, Montreal, QC, Canada, ³Jewish General Hospital, McGill University, Montreal, QC, Canada, ⁴Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: Persons with lower socioeconomic status (SES) have poorer health status for many medical conditions. Reasons for this finding are multiple, but access to care,…
Abstract Number: 839 • 2013 ACR/ARHP Annual Meeting
A Paradigm Change for Treatment Strategies for Fibromyalgia Syndrome Reflected By Recommendations of Recent Evidence-Based Interdisciplinary Guidelines Developed Independently in Three Countries
Jacob N. Ablin¹, Dan Buskila², Howard Amital³, Mary-Ann Fitzcharles⁴, Yoram Shir⁵, Peter Henningsen⁶ and Winfried Häuser⁷, ¹Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, ²Ben-Gurion University, Beer-Sheva, Israel, ³Department of Medicine B, Center for Autoimmune Diseases, Sheba Medical Center, Tel-hashomer, Israel, ⁴Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ⁵Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ⁶Department Internal Medicine I, Klinikum Saarbrücken, Saarbrücken, Germany, ⁷Klinikum Saarbrücken, Saarbrücken, Germany
Background/Purpose: Although the ideal treatment for fibromyalgia (FM) remains elusive, the medical community requires direction in the care of these patients. The literature however abounds…
Abstract Number: 136 • 2013 ACR/ARHP Annual Meeting
The Detection Of Primary Hyperparathyroidism In Patients Diagnosed With Fibromyalgia
Michael Tsoukas¹, Peter A. Ste-Marie², Yoram Shir², Mary-Ann Fitzcharles³ and Elliot Mitmaker⁴, ¹Endocrinology, McGill University Health Centre, Montreal, QC, Canada, ²Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ³Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ⁴General and Endocrine Surgery, McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: Some illnesses, such as hypothyroidism or small fiber neuropathy, may present similarly to fibromyalgia (FM), or may in turn lead to an augmented polysymptomatic…
Abstract Number: 841 • 2013 ACR/ARHP Annual Meeting
The Prevalence Of Fibromyalgia In The General Population – a Comparison Of The ACR 1990, 2010 and Modified 2010 Classification Criteria
Gareth T. Jones¹, Marcus Beasley¹, Fabiola Atzeni², Elisa Flüß¹, Piercarlo Sarzi-Puttini² and Gary Macfarlane¹, ¹Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, ²Rheumatology Unit, L. Sacco University Hospital, Milan, Italy
Background/Purpose: In 1990 the ACR published criteria for the classification of fibromyalgia (FM), based on widespread pain and tenderness. In 2010 new criteria were published…
Abstract Number: 842 • 2013 ACR/ARHP Annual Meeting
A Cytokine/Chemokine Multiplex Assay That Is Sensitive and Specific For Fibromyalgia Compared To Controls, Systemic Lupus Erythematosus, and Rheumatoid Arthritis
Daniel J. Wallace¹, Igor Gavin², Oleksiy Karpenko² and Bruce S. Gillis³, ¹Cedars-Sinai Medical Center, Los Angeles, CA, ²University of Illinois College of Medicine at Chicago, Chicago, IL, ³Department of Pathology, University of Illinois College of Medicine at Chicago, Chicago, IL
Background/Purpose: Fibromyalgia (FM) is a chronic pain and fatigue syndrome that affects about 6 million adults in the United States. The clinical diagnosis of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].